Optimal Contact Position of Subthalamic Nucleus Deep Brain Stimulation for Reducing Restless Legs Syndrome in Parkinson’s Disease Patients: One-Year Follow-Up with 33 Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. Inclusion Criteria
2.2. Preoperative Evaluation and Postoperative Follow-Up
2.3. Neuroimaging Data
2.4. DBS Implant
2.5. Position of Electrodes and Contacts
2.6. Statistical Analysis
3. Results
3.1. Clinical Data Related to PD Patients STN-DBS
3.2. Efficacy of STN-DBS on RLS Symptoms
3.2.1. CGI Score for STN-DBS Alleviated RLS at One-Year Follow-Up
3.2.2. IRLS, MOS Sleep and RLS QoL Scores between Pre-Operation and Post-Operation 1-Rear Follow-Up
3.2.3. Changes in Anti-Parkinsonism Medication in RLS Group Pre- and Post-Operation
3.3. Stimulation Parameters for the RLS Group
3.4. Changes in RLS Symptoms during Follow-Up
3.5. Electrical-Stimulation-Induced Acute RLS Symptoms
4. Discussion
4.1. Benefit of STN-DBS in Reducing RLS Symptoms
4.2. Postoperative Medication Adjustment Strategies
4.3. The Stimulation Coordinates according to the AC-PC Coordinates
4.4. Programming for RLS
4.5. Causes of Newly Emerged RLS after STN-DBS
4.6. STN-DBS Neural Network for RLS Mitigation
4.7. Study Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lees, A.J.; Hardy, J.; Revesz, T. Parkinson’s disease. Lancet 2009, 373, 2055–2066. [Google Scholar] [CrossRef] [PubMed]
- Rijsman, R.M.; Schoolderman, L.F.; Rundervoort, R.S.; Louter, M. Restless legs syndrome in Parkinson’s disease. Parkinsonism Relat. Disord. 2014, 20 (Suppl. S1), S5–S9. [Google Scholar] [CrossRef] [PubMed]
- Fereshtehnejad, S.M.; Shafieesabet, M.; Shahidi, G.A.; Delbari, A.; Lökk, J. Restless legs syndrome in patients with Parkinson’s disease: A comparative study on prevalence, clinical characteristics, quality of life and nutritional status. Acta Neurol. Scand. 2015, 131, 211–218. [Google Scholar] [CrossRef] [PubMed]
- Coccagna, G.; Vetrugno, R.; Lombardi, C.; Provini, F. Restless legs syndrome: An historical note. Sleep Med. 2004, 5, 279–283. [Google Scholar] [CrossRef]
- Yang, X.; Liu, B.; Shen, H.; Li, S.; Zhao, Q.; An, R.; Hu, F.; Ren, H.; Xu, Y.; Xu, Z. Prevalence of restless legs syndrome in Parkinson’s disease: A systematic review and meta-analysis of observational studies. Sleep Med. 2018, 43, 40–46. [Google Scholar] [CrossRef]
- De Cock, V.C. Therapies for Restless Legs in Parkinson’s Disease. Curr. Treat. Options Neurol. 2019, 21, 56. [Google Scholar] [CrossRef]
- Weaver, F.M.; Follett, K.; Stern, M.; Hur, K.; Harris, C.; Marks, W.J.; Rothlind, J.; Sagher, O.; Reda, M.; Moy, C.S.; et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial. JAMA 2009, 301, 63–73. [Google Scholar] [CrossRef] [Green Version]
- Chahine, L.M.; Ahmed, A.; Sun, Z. Effects of STN DBS for Parkinson’s disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat. Disord. 2011, 17, 208–211. [Google Scholar] [CrossRef]
- Driver-Dunckley, E.; Evidente, V.G.; Adler, C.H.; Hillman, R.; Ba, J.H.; Fletcher, G.; Lyons, M.K. Restless legs syndrome in Parkinson’s disease patients may improve with subthalamic stimulation. Mov. Disord. Off. J. Mov. Disord. Soc. 2006, 21, 1287–1289. [Google Scholar] [CrossRef]
- Klepitskaya, O.; Liu, Y.; Sharma, S.; Sillau, S.H.; Tsai, J.; Walters, A.S. Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease. Neurology 2018, 91, e1013–e1021. [Google Scholar] [CrossRef]
- Dulski, J.; Waz, P.; Konkel, A.; Grabowski, K.; Libionka, W.; Schinwelski, M.; Ma, E.J.S. The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson’s Disease. Neuromodulation J. Int. Neuromodulation Soc. 2021, 25, 904–910. [Google Scholar] [CrossRef] [PubMed]
- Marques, A.; Fantini, M.L.; Morand, D.; Pereira, B.; Derost, P.; Ulla, M.; Debilly, B.; Lemaire, J.-J.; Durif, F. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson’s disease: A dopaminergic overstimulation? Sleep Med. 2015, 16, 583–588. [Google Scholar] [CrossRef] [PubMed]
- Kedia, S.; Moro, E.; Tagliati, M.; Lang, A.E.; Kumar, R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004, 63, 2410–2412. [Google Scholar] [CrossRef] [PubMed]
- Postuma, R.B.; Berg, D.; Stern, M.; Poewe, W.; Olanow, C.W.; Oertel, W.; Obeso, J.; Marek, K.; Litvan, I.; Lang, A.E.; et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 2015, 30, 1591–1601. [Google Scholar] [CrossRef] [PubMed]
- Allen, R.P.; Picchietti, D.L.; Garcia-Borreguero, D.; Ondo, W.G.; Walters, A.S.; Winkelman, J.W.; Zucconi, M.; Ferri, R.; Trenkwalder, C.; Lee, H.B. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014, 15, 860–873. [Google Scholar] [CrossRef]
- Morgan, J.C.; Sethi, K.D. Efficacy and safety of pramipexole in restless legs syndrome. Curr. Neurol. Neurosci. Rep. 2007, 7, 273–274. [Google Scholar] [CrossRef]
- Coenen, V.A.; Abdel-Rahman, A.; McMaster, J.; Bogod, N.; Honey, C.R. Minimizing brain shift during functional neurosurgical procedures—A simple burr hole technique that can decrease CSF loss and intracranial air. Cent. Eur. Neurosurg. 2011, 72, 181–185. [Google Scholar] [CrossRef]
- Yang, C.; Qiu, Y.; Wu, X.; Wang, J.; Wu, Y.; Hu, X. Analysis of Contact Position for Subthalamic Nucleus Deep Brain Stimulation-Induced Hyperhidrosis. Parkinsons. Dis. 2019, 2019, 8180123. [Google Scholar] [CrossRef] [Green Version]
- Ashburner, J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38, 95–113. [Google Scholar] [CrossRef]
- Tao, R.; Xue, C.; Yang, C.; Simfukwe, K.; Hu, X.; Wu, X.; Bi, H. Reconstruction of chronic scalp erosion after deep brain stimulation surgery. J. Plast. Reconstr. Aesthet. Surg. 2021, 74, 1807–1813. [Google Scholar] [CrossRef]
- Liu, C.F.; Wang, T.; Zhan, S.Q.; Geng, D.-Q.; Wang, J.; Liu, J.; Shang, H.-F.; Wang, L.-J.; Chan, P.; Chen, H.-B.; et al. Management Recommendations on Sleep Disturbance of Patients with Parkinson’s Disease. Chin. Med. J. 2018, 131, 2976–2985. [Google Scholar] [CrossRef] [PubMed]
- Loddo, G.; Calandra-Buonaura, G.; Sambati, L.; Giannini, G.; Cecere, A.; Cortelli, P.; Provini, F. The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice. Front. Neurol. 2017, 8, 42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Avecillas-Chasin, J.M.; Honey, C.R. Modulation of Nigrofugal and Pallidofugal Pathways in Deep Brain Stimulation for Parkinson Disease. Neurosurgery 2020, 86, E387–E397. [Google Scholar] [CrossRef] [PubMed]
- Welter, M.L.; Schupbach, M.; Czernecki, V.; Karachi, C.; Fernandez-Vidal, S.; Golmard, J.-L.; Serra, G.; Navarro, S.; Welaratne, A.; Hartmann, A.; et al. Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology 2014, 82, 1352–1361. [Google Scholar] [CrossRef] [Green Version]
- Aquino, C.C.; Duffley, G.; Hedges, D.M.; Vorwerk, J.; House, P.A.; Ferraz, H.B.; Rolston, J.D.; Butson, C.R.; Schrock, L.E. Interleaved deep brain stimulation for dyskinesia management in Parkinson’s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 2019, 34, 1722–1727. [Google Scholar] [CrossRef]
- Picillo, M.; Lozano, A.M.; Kou, N.; Munhoz, R.P.; Fasano, A. Programming Deep Brain Stimulation for Parkinson’s Disease: The Toronto Western Hospital Algorithms. Brain Stimul. 2016, 9, 425–437. [Google Scholar] [CrossRef]
- Baizabal-Carvallo, J.F.; Jankovic, J. Movement disorders induced by deep brain stimulation. Parkinsonism Relat. Disord. 2016, 25, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Rye, D.B.; DeLong, M.R. Amelioration of sensory limb discomfort of restless legs syndrome by pallidotomy. Ann. Neurol. 1999, 46, 800–801. [Google Scholar] [CrossRef]
- Tolleson, C.M.; Bagai, K.; Walters, A.S.; Davis, T.L. A Pilot Study Assessing the Effects of Pallidal Deep Brain Stimulation on Sleep Quality and Polysomnography in Parkinson’s Patients. Neuromodulation J. Int. Neuromodulation Soc. 2016, 19, 724–730. [Google Scholar] [CrossRef] [Green Version]
- Ondo, W.G.; Jankovic, J.; Simpson, R.; Jimenez-Shahed, J. Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome. Sleep Med. 2012, 13, 1202–1204. [Google Scholar] [CrossRef]
- Zhang, C.; Lai, Y.; Li, J.; He, N.; Liu, Y.; Li, Y.; Li, H.; Wei, H.; Yan, F.; Horn, A.; et al. Subthalamic and Pallidal Stimulations in Patients with Parkinson’s Disease: Common and Dissociable Connections. Ann. Neurol. 2021, 90, 670–682. [Google Scholar] [CrossRef] [PubMed]
- Basinger, H.; Joseph, J. Neuroanatomy, Subthalamic Nucleus. In StatPearls; Basinger, H., Joseph, J., Eds.; Treasure Island: Bristol, UK, 2022. [Google Scholar]
- Winkelman, J.W.; Armstrong, M.J.; Allen, R.P.; Chaudhuri, K.R.; Ondo, W.; Trenkwalder, C.; Zee, P.C.; Gronseth, G.S.; Gloss, D.; Zesiewicz, T. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2016, 87, 2585–2593. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ruppert, E.; Hacquard, A.; Tatu, L.; Namer, I.J.; Wolff, V.; Kremer, S.; Lagha-Boukbiza, O.; Bataillard, M.; Bourgin, P. Stroke-related restless legs syndrome: Clinical and anatomo-functional characterization of an emerging entity. Eur. J. Neurol. 2021, 29, 1011–1016. [Google Scholar] [CrossRef] [PubMed]
- Hidding, U.; Gulberti, A.; Pflug, C.; Choe, C.; Horn, A.; Prilop, L.; Braaß, H.; Fründt, O.; Buhmann, C.; Weiss, D.; et al. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson’s disease. Parkinsonism Relat. Disord. 2019, 62, 141–147. [Google Scholar] [CrossRef]
Items | RLS Group (n = 33) | Non-RLS Group (n = 330) | p-Value |
---|---|---|---|
Age | 62.97 ± 6.41 | 62.15 ± 7.93 | 0.074 |
Disease duration | 9.45 ± 4.21 | 10.66 ± 4.27 | 0.891 |
Gender(M/F) | 14/19 | 164/166 | 0.426 a |
UPDRS-Ⅲ(pre-OP, med-off) | 58.09 ± 14.60 | 59.08 ± 17.26 | 0.283 |
UPDRS-Ⅲ(pre-OP, med-on) | 24.55 ± 10.09 | 27.58 ± 13.76 | 0.161 |
LCT (%) | 57.56% (P50), 57.25 ± 14.80 | 55.00 (P50), 54.69 ± 16.28 | 0.307 |
H-Y (1.5/2/2.5/3/4/5) Grade | 0/1/6/18/8/0 | 3/11/62/191/62/1 | 0.968 b |
LEDD pre-OP | 800.00 (P50), 810.52 ± 297.61 | 800.00 (P50), 821.35 ± 439.02 | 0.976 c |
UPDRS-Ⅲ (post-OP, med-off, IPG-off) | 49.50 (P50), 50.57 ± 17.91 | 50.00 (P50), 51.08 ± 16.63 | 0.802 |
UPDRS-Ⅲ (post-OP, med-off, IPG-on) | 25.00 (P50), 27.37 ± 11.39 | 26.00 (P50), 27.38 ± 11.67 | 0.930 |
UPDRS-Ⅲ (post-OP, med-on, IPG-off ) | 22.00 (P50), 21.18 ± 10.12 | 21.00 (P50), 21.54 ± 9.62 | 0.851 |
Items | Pre-Operation (Mean ± sd, P50) | Post-Operation (Mean ± sd, P50) | p-Value |
---|---|---|---|
IRLS | |||
Discomfort | 2.18 ± 0.85 | 1.09 ± 0.77 | <0.001 |
Need to move | 1.91 ± 0.84 | 0.76 ± 0.87 | <0.001 |
Relief | 1.91 ± 0.88 | 1.30 ± 1.16 | 0.002 |
Sleep disturbance | 1.85 ± 1.00 | 0.70 ± 0.77 | <0.001 |
During the day (Tiredness or sleepiness) | 1.39 ± 1.06 | 0.33 ± 0.54 | <0.001 |
RLS on the whole | 1.85 ± 1.00 | 0.73 ± 1.01 | <0.001 |
How often | 2.39 ± 1.17 | 1.27 ± 1.26 | <0.001 |
How severe | 2.03 ± 0.88 | 0.97 ± 0.85 | <0.001 |
Daily activities | 1.88 ± 0.99 | 0.61 ± 0.79 | <0.001 |
Mood disturbance | 1.36 ± 0.99 | 0.36 ± 0.60 | <0.001 |
IRLS sumscore | 18 (P50), 18.76 ± 7.71 | 16 (P50), 8.12 ± 7.08 | <0.001 * |
MOS sleep | |||
Sleep disturbance | 52.17 (P50), 57.44 ± 18.28 | 34.78 (P50), 40.45 ± 15.73 | <0.001 |
Sleep adequacy | 50.00 (P50), 49.75 ± 14.51 | 66.67 (P50), 69.95 ± 13.49 | <0.001 |
Daytime somnolence | 83.33 (P50), 80.30 ± 15.90 | 88.89 (P50), 85.52 ± 10.29 | 0.005 |
Snoring | 16.67 (P50), 26.04 ± 20.27 | 16.67 (P50), 21.72 ± 14.72 | 0.072 |
Shortness of breath or headache | 16.67 (P50), 25.76 ± 16.71 | 16.67 (P50), 22.73 ± 13.70 | 0.109 |
Sleep quantity | 5.00 (P50), 4.82 ± 1.16 | 6.00 (P50), 5.94 ± 1.32 | <0.001 |
RLS Quality of Life Questionnaire | |||
RLS QoL transformed score (1–5, 7–10, 13 items) | 70.00 (P50),63.79 ± 22.60 | 92.50(P50),86.59 ± 16.59 | <0.001 † |
Items | Pre-Operation (P50, Mean ± sd) | Post-Operation (P50, Mean ± sd) | p-Value |
---|---|---|---|
Levodopa equivalent daily dose (LEDD) | 814.99 ± 297.61 | 386.42 ± 235.81 | <0.001 # |
Total Levodopa and COMT dose | 600 (P50), 665.75 ± 264.96 | 300 (P50), 323.54 ± 170.8 | <0.001 |
Dopamine agonist (DA) | 75.00 (P50), 80.30 ± 65.10 | 25 (P50), 38.64 ± 45.11 | 0.001 |
Amantadine daily doses | 0 (P50), 59.09 ± 97.99 | 0 (P50), 21.21 ± 69.63 | 0.017 |
Total MAO-B dose | 0 (P50), 9.85 ± 27.91 | 0 (P50), 3.03 ± 17.41 | 0.109 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lei, H.; Yang, C.; Zhang, M.; Qiu, Y.; Wang, J.; Xu, J.; Hu, X.; Wu, X. Optimal Contact Position of Subthalamic Nucleus Deep Brain Stimulation for Reducing Restless Legs Syndrome in Parkinson’s Disease Patients: One-Year Follow-Up with 33 Patients. Brain Sci. 2022, 12, 1645. https://doi.org/10.3390/brainsci12121645
Lei H, Yang C, Zhang M, Qiu Y, Wang J, Xu J, Hu X, Wu X. Optimal Contact Position of Subthalamic Nucleus Deep Brain Stimulation for Reducing Restless Legs Syndrome in Parkinson’s Disease Patients: One-Year Follow-Up with 33 Patients. Brain Sciences. 2022; 12(12):1645. https://doi.org/10.3390/brainsci12121645
Chicago/Turabian StyleLei, Hongbing, Chunhui Yang, Mingyang Zhang, Yiqing Qiu, Jiali Wang, Jinyu Xu, Xiaowu Hu, and Xi Wu. 2022. "Optimal Contact Position of Subthalamic Nucleus Deep Brain Stimulation for Reducing Restless Legs Syndrome in Parkinson’s Disease Patients: One-Year Follow-Up with 33 Patients" Brain Sciences 12, no. 12: 1645. https://doi.org/10.3390/brainsci12121645